Salvage therapy with pentostatin for steroid-refractory graft-versus-host disease

被引：0

作者：

Leopardi, G ^{[1
]}

Visani, G ^{[1
]}

Giardini, C ^{[1
]}

Sparaventi, G ^{[1
]}

d'Adamo, F ^{[1
]}

Nicolini, G ^{[1
]}

Guiducci, B ^{[1
]}

Barulli, S ^{[1
]}

Malerba, L ^{[1
]}

Lucesole, M ^{[1
]}

Isidori, A ^{[1
]}

机构：

[1] San Salvatore Hosp, Pesaro, Italy

来源：

BONE MARROW TRANSPLANTATION | 2006年 / 37卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：S97 / S97

页数：1

共 50 条

[31] EFFICACY AND SAFETY OF INFLIXIMAB THERAPY IN THE SETTING OF STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Halahleh, Khalid
Al Shurman, Jana
Taqash, Ayat
Ma'koseh, Mohammad
Abu Khader, Ahmad
Muradi, Isra
Da'na, Waleed
Rihani, Rawad
BONE MARROW TRANSPLANTATION, 2024, 59 : 340 - 341
[32] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
Nikiforow, Sarah
Kim, Haesook T.
Bindra, Bhavjot
McDonough, Sean
Glotzbecker, Brett
Armand, Philippe
Koreth, John
Ho, Vincent T.
Alyea, Edwin P., III
Blazar, Bruce R.
Ritz, Jerome
Soiffer, Robert J.
Antin, Joseph H.
Cutler, Corey S.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
[33] COMBINATION THERAPY WITH INOLIMOMAB AND ETANERCEPT FOR SEVERE STEROID-REFRACTORY ACUTE GRAFT-VERSUS-HOST DISEASE
Van Groningen, L.
Liefferink, A.
de Haan, A.
Schaap, N.
Donnelly, P.
Blijlevens, N.
van der Velden, W.
HAEMATOLOGICA, 2015, 100 : 279 - 279
[34] Safety and Efficacy of Infliximab Therapy in the Setting of Steroid-Refractory Acute Graft-versus-Host Disease
Yalniz, Fevzi E.
Hefazi, Mehrdad
McCullough, Kristen
Litzow, Mark R.
Hogan, William J.
Wolf, Robert
Alkhateeb, Hassan
Kansagra, Ankit
Damlaj, Moussab
Patnaik, Mrinal M.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1478 - 1484
[35] Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients
Khandelwal, Pooja
Teusink-Cross, Ashley
Davies, Stella M.
Nelson, Adam S.
Dandoy, Christopher E.
El-Bietar, Javier
Marsh, Rebecca A.
Kumar, Ashish R.
Grimley, Michael S.
Jodele, Sonata
Myers, Kasiani C.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (07) : 1122 - 1127
[36] Strategy on the Treatment of Steroid-Refractory Severe acute Graft-versus-Host Disease
Yamin, T.
Yi, L.
Kaili, D.
He, H.
BONE MARROW TRANSPLANTATION, 2015, 50 : S393 - S394
[37] Treatment of steroid-refractory acute graft-versus-host disease with ATG (Fresenius)
Kamelander, J.
Navratil, M.
Koristek, Z.
Doubek, M.
Krejci, M.
Brychtova, Y.
Racil, Z.
Mendelova, D.
Weinreb, M.
Mayer, J.
BONE MARROW TRANSPLANTATION, 2008, 41 : S241 - S241
[38] Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease
Benito, AI
Furlong, T
Martin, PJ
Anasetti, C
Appelbaum, FR
Doney, K
Nash, RA
Papayannopoulou, T
Storb, R
Sullivan, KM
Witherspoon, R
Deeg, HJ
TRANSPLANTATION, 2001, 72 (12) : 1924 - 1929
[39] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
Meunier, Mathieu
Bulabois, Claude Eric
Thiebaut-Bertrand, Anne
Itzykson, Raphael
Carre, Martin
Carras, Sylvain
Garban, Frederic
Cahn, Jean Yves
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
[40] Hedgehog blockade in steroid-refractory sclerotic chronic graft-versus-host disease
Radojcic, Vedran
Pletneva, Maria
Lee, Catherine J.
Ivcevic, Sanja
Sarantopoulos, Stefanie
Couriel, Daniel
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 195 (02) : E120 - E122

← 1 2 3 4 5 →